Preclinical evidence is encouraging but preliminary
BPC-157 is a research peptide not approved by Health Canada for human therapeutic use
Bacteriostatic water serves as the reconstitution medium, with its benzyl alcohol content providing preservation that extends shelf life
Fat: The Absorption Showdown The standard approach is injecting into muscle (intramuscular), but some people actually do better with shots just under the skin (subcutaneous) using smaller amounts
ADVERSE EFFECTS In the cagrilintide, single-agent study between 2% and 6% (26%) of participants in the cagrilintide groups discontinued treatment prematurely because of adverse events, compared with 7% (7%) of participants in the liraglutide 3.0 mg group and 3% (3%) in the pooled placebo group
At the 8mg maintenance dose, you are using 80% of a 10mg vial per week, meaning you need roughly one vial per week